Features, pricing, ratings, and pros & cons — compared head-to-head.
360 High-Risk Vulnerability Immunization Tool V2.0 is a commercial vulnerability assessment tool by 360 Security Group (Qihoo 360). Cogent is a commercial vulnerability assessment tool by Cogent Security. Compare features, ratings, integrations, and community reviews side by side to find the best vulnerability assessment fit for your security stack.
Based on our analysis of NIST CSF 2.0 coverage, core features, company size fit, deployment model, here is our conclusion:
360 High-Risk Vulnerability Immunization Tool V2.0
Startups and SMBs with Windows-heavy infrastructure and patching backlogs should run 360 High-Risk Vulnerability Immunization Tool V2.0 first; it immunizes against the specific CVEs that drive ransomware campaigns (MS17-010, CVE-2019-0708) without requiring immediate OS updates. The tool supports Windows 7 through current versions and deploys on-premises, meaning air-gapped networks can actually use it. Skip this if you're looking for NIST PR.PS coverage beyond platform hardening,this tool stops known exploits, not supply chain attacks or firmware-level threats.
Mid-market and enterprise security teams drowning in vulnerability backlogs will see immediate value from Cogent because its AI agent actually closes the loop between detection and remediation rather than just ranking what to fix. The platform covers ID.AM through RS.MI across the NIST framework, but the real differentiator is ROI-based action planning that tells you which vulnerabilities actually matter to your business and then orchestrates the fix without manual hand-offs. Skip this if your team needs deep integration with legacy SIEM platforms or if you're looking for a scanner replacement; Cogent assumes you already have asset data flowing in and wants to solve the remediation bottleneck instead.
Tool that immunizes Windows systems against critical vulnerabilities
AI-driven vulnerability management platform with automated remediation
Access NIST CSF 2.0 data from thousands of security products via MCP to assess your stack coverage.
Access via MCPNo reviews yet
No reviews yet
Explore more tools in this category or create a security stack with your selections.
Common questions about comparing 360 High-Risk Vulnerability Immunization Tool V2.0 vs Cogent for your vulnerability assessment needs.
360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..
Cogent: AI-driven vulnerability management platform with automated remediation. built by Cogent Security. Core capabilities include Real-time context ingestion from security and IT environments, Dynamic risk prioritization of vulnerabilities, ROI-based action planning for remediation..
Both serve the Vulnerability Assessment market but differ in approach, feature depth, and target audience.
360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. Cogent differentiates with Real-time context ingestion from security and IT environments, Dynamic risk prioritization of vulnerabilities, ROI-based action planning for remediation.
360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). Cogent is developed by Cogent Security. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.
360 High-Risk Vulnerability Immunization Tool V2.0 and Cogent serve similar Vulnerability Assessment use cases: both are Vulnerability Assessment tools. Review the feature comparison above to determine which fits your requirements.
Get strategic cybersecurity insights in your inbox